1. Beyond keratinocyte differentiation: emerging new biology of small proline-rich proteins. Issue 1 (January 2023) Authors: Zabini, Adam; Zimmer, Yitzhak; Medová, Michaela Journal: Trends in cell biology Issue: Volume 33:Issue 1(2023) Page Start: 5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Deciphering MET‐dependent modulation of global cellular responses to DNA damage by quantitative phosphoproteomics. Issue 6 (13th May 2020) Authors: Bensimon, Ariel; Koch, Jonas P.; Francica, Paola; Roth, Selina M.; Riedo, Rahel; Glück, Astrid A.; Orlando, Eleonora; Blaukat, Andree; Aebersold, Daniel M.; Zimmer, Yitzhak; Aebersold, Ruedi; Medová, Michaela Journal: Molecular oncology Issue: Volume 14:Issue 6(2020) Page Start: 1185 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Interplay between receptor tyrosine kinases and hypoxia signaling in cancer. (May 2015) Authors: Glück, Astrid A.; Aebersold, Daniel M.; Zimmer, Yitzhak; Medová, Michaela Journal: International journal of biochemistry & cell biology Issue: Volume 62(2015:May) Page Start: 101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. KRAS and HRAS mutations confer resistance to MET targeting in preclinical models of MET‐expressing tumor cells. Issue 7 (14th April 2015) Authors: Leiser, Dominic; Medová, Michaela; Mikami, Kei; Nisa, Lluís; Stroka, Deborah; Blaukat, Andree; Bladt, Friedhelm; Aebersold, Daniel M.; Zimmer, Yitzhak Journal: Molecular oncology Issue: Volume 9:Issue 7(2015:Aug.) Page Start: 1434 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Metabolomics reveals tepotinib‐related mitochondrial dysfunction in MET‐activating mutations‐driven models. (11th May 2019) Authors: Poliaková, Michaela; Felser, Andrea; Pierzchala, Katarzyna; Nuoffer, Jean‐Marc; Aebersold, Daniel Matthias; Zimmer, Yitzhak; Zamboni, Nicola; Medová, Michaela Journal: FEBS journal Issue: Volume 286:Number 14(2019) Page Start: 2692 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OMIP‐045: Characterizing human head and neck tumors and cancer cell lines with mass cytometry. Issue 4 (12th April 2018) Authors: Brodie, Tess M.; Tosevski, Vinko; Medová, Michaela Journal: Cytometry Issue: Volume 93:Issue 4(2018) Page Start: 406 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. OMIP‐045: Characterizing human head and neck tumors and cancer cell lines with mass cytometry. Issue 4 (12th April 2018) Authors: Brodie, Tess M.; Tosevski, Vinko; Medová, Michaela Journal: Cytometry Issue: Volume 93:Issue 4(2018) Page Start: 406 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Oncogene addiction as a foundation of targeted cancer therapy: The paradigm of the MET receptor tyrosine kinase. (28th February 2019) Authors: Orlando, Eleonora; Aebersold, Daniel Matthias; Medová, Michaela; Zimmer, Yitzhak Journal: Cancer letters Issue: Volume 443(2019) Page Start: 189 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Targeting of the MET receptor tyrosine kinase by small molecule inhibitors leads to MET accumulation by impairing the receptor downregulation. Issue 5 (17th January 2014) Authors: Leiser, Dominic; Pochon, Benoît; Blank-Liss, Wieslawa; Francica, Paola; Glück, Astrid A.; Aebersold, Daniel M.; Zimmer, Yitzhak; Medová, Michaela Journal: FEBS letters Issue: Volume 588:Issue 5(2014) Page Start: 653 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗